| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.34B | 1.35B | 1.27B | 1.30B | 1.25B | 1.28B |
| Gross Profit | 1.18B | 1.19B | 1.13B | 1.15B | 1.11B | 1.15B |
| EBITDA | 379.08M | 378.56M | 399.81M | 345.57M | 318.89M | 450.37M |
| Net Income | 240.52M | 255.02M | 261.82M | 200.66M | 184.09M | 310.23M |
Balance Sheet | ||||||
| Total Assets | 3.19B | 3.23B | 3.13B | 2.99B | 2.70B | 3.12B |
| Cash, Cash Equivalents and Short-Term Investments | 644.58M | 702.60M | 577.75M | 957.11M | 817.58M | 1.27B |
| Total Debt | 40.64M | 38.88M | 46.99M | 50.65M | 50.94M | 72.12M |
| Total Liabilities | 589.25M | 595.81M | 643.72M | 622.38M | 451.15M | 518.66M |
| Stockholders Equity | 2.59B | 2.62B | 2.48B | 2.36B | 2.25B | 2.60B |
Cash Flow | ||||||
| Free Cash Flow | 379.68M | 430.26M | 297.25M | 336.74M | 259.12M | 393.30M |
| Operating Cash Flow | 420.22M | 472.20M | 327.25M | 367.08M | 318.58M | 447.75M |
| Investing Cash Flow | -1.20M | -10.59M | -286.29M | 54.21M | -295.94M | -44.91M |
| Financing Cash Flow | -311.50M | -247.24M | -287.81M | -236.81M | -610.56M | -252.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $61.18B | 19.39 | 32.85% | 2.58% | 4.62% | 1.06% | |
77 Outperform | $137.59B | 18.49 | 25.35% | 2.25% | 6.58% | 1.19% | |
74 Outperform | $6.19B | 26.15 | 9.43% | 2.05% | 5.92% | -2.98% | |
71 Outperform | $31.95B | 14.65 | 15.16% | 1.46% | 7.44% | -4.57% | |
67 Neutral | $20.80B | 19.72 | 41.79% | 1.63% | 8.57% | 35.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $11.36B | 16.26 | 86.85% | ― | 5.24% | -16.05% |
At its 2026 Annual Meeting of Stockholders held via live webcast on February 3, 2026, Dolby Laboratories’ shareholders elected eight directors to serve until the 2027 annual meeting or until their successors are duly elected and qualified, reaffirming the company’s existing board composition. Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers and ratified the appointment of KPMG LLP as Dolby’s independent registered public accounting firm for the fiscal year ending September 25, 2026, signaling continued support for the company’s executive pay practices and its chosen external auditor under the firm’s dual-class share voting structure.
The most recent analyst rating on (DLB) stock is a Buy with a $71.00 price target. To see the full list of analyst forecasts on Dolby Laboratories stock, see the DLB Stock Forecast page.
On January 29, 2026, Dolby Laboratories reported first-quarter fiscal 2026 revenue of $347 million, down from $357 million a year earlier, with GAAP net income slipping to $53 million, or $0.55 per diluted share, and non-GAAP earnings of $1.06 per share versus $1.14 in the prior-year quarter. The company underscored continued adoption of Dolby Atmos and Dolby Vision across automotive and streaming, highlighting uptake by more than 35 auto OEMs, new integrations with Mercedes-Benz, Mahindra and Qualcomm’s Gen 5 Snapdragon Automotive platform, as well as broader use of Dolby Vision and Atmos by Peacock, major TV brands including Hisense, TCL and TP Vision, LG’s new Dolby Atmos FlexConnect-based sound system, and Meta’s support for Dolby Vision on Facebook and Instagram. Dolby returned capital to shareholders by repurchasing about one million shares for roughly $70 million and declared a $0.36 per-share dividend payable on February 18, 2026 to stockholders of record on February 10, 2026, while issuing guidance for fiscal 2026 that envisions total revenue between $1.4 billion and $1.45 billion, very high gross margins near 90% and non-GAAP operating margins in the mid-30% range, despite acknowledging macroeconomic and geopolitical uncertainties that could weigh on royalty-based licensing revenue.
The most recent analyst rating on (DLB) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Dolby Laboratories stock, see the DLB Stock Forecast page.
On November 18, 2025, Dolby Laboratories announced its financial results for the fourth quarter and fiscal year 2025, reporting a total revenue of $307 million for the quarter and $1.35 billion for the year. The company highlighted growth in its Dolby Atmos and Dolby Vision technologies, as well as new partnerships and product launches, indicating a strong market position as it heads into fiscal year 2026.
The most recent analyst rating on (DLB) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on Dolby Laboratories stock, see the DLB Stock Forecast page.
On November 11, 2025, Dolby Laboratories‘ Compensation Committee approved the 2026 Executive Bonus Plan, targeting executive officers with bonuses based on a percentage of their base salary. The plan emphasizes achieving non-GAAP operating income and revenue goals, with potential adjustments by the Committee, impacting the final bonus amounts for executives.
The most recent analyst rating on (DLB) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on Dolby Laboratories stock, see the DLB Stock Forecast page.